Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Positron Corporation announced it has placed orders on its sales of three Attrius PET scanners

Positron Corporation , a leading molecular imaging company specializing in the field of nuclear cardiology, announced it has placed orders on its sales of three Attrius PET scanners. The sales of these systems are for leading cardiology practices and hospitals. The Company also reaffirmed its growth targets as previously disclosed, and is anticipating steady growth acceleration through 2012.

"The outlook for 2010 and beyond is very promising - with our leading market position and steady increase of new orders, the next few years should be an exciting period for Positron. Cardiac PET is the future of nuclear cardiology and we believe the investments made in equipment and infrastructure should allow us to meet the growing interest in PET. Our overriding objective is to meet the strong demand and be the provider of choice for cardiac PET adopters," said Patrick G. Rooney, chief executive officer of Positron. "While we're extremely focused on excelling in this rapidly growing field, we're also very focused on expanding our pharmaceutical business. This enables us to combine our unique products in innovative ways that provides the full package to the cardiology industry. All of our actions have one common goal in mind of increasing the bottom line that will deliver value to our shareholders."

Positron has received additional orders during the third quarter of 2010 and anticipates the fourth quarter will be its strongest yet. With the current run rate, the Company fully anticipates by the end of 2010 it will reach its sales goal of approximately 12 to 15 Attrius(TM) PET systems which equates to approximately $10 million to $12 million in sales, part of which will be recognized in the first quarter of 2011. The Company also expects to begin generating revenue from its radiopharmaceutical distribution and manufacturing businesses, which should come on line at the beginning of the fourth quarter.

Source: Positron Corporation